The aim of this study was to evaluate the distribution of the APOE e4 genotype in AD, L-aMCI, E-aMCI, SMI, and control groups in a relatively large cohort of patients across the full clinical AD spectrum, and to compare the frequency of the genotype between the different diagnostic categories. Here, APOE is linked to Alzheimer disease.